Statistically significant differences in the receipt of chemotherapy exist among elderly patients with SCLC. Chemotherapy is associated with a greater than 6-month improvement in median survival among elderly patients with SCLC, even in patients over the age of 80 years.
Co-existing COPD is associated with worse survival outcomes in early-stage NSCLC patients, particularly for men and for SCC.
The FDG uptake in PET may be a predictive factor for AE of ILD in patients who have undergone lung cancer surgery.
The amount of elastic fiber in fibrotic tissue is a prognostic indicator in patients with IPF.
Conclusions: The duration of the ECMO bridge is a relevant cofactor in the mortality and morbidity of critically ill patients awaiting organ allocation. The NIV strategy was associated with a less complicated clinical course after LTX.
Conclusions: In a longitudinal multicenter population of adults with CF, clinical variables such as FEV1, exacerbation frequency, and weight were correlated with related CFQ-R subscales. For the population as a whole, the physical domains of CFQ-R, such as respiratory symptoms, were stable. In contrast, population changes in several psychosocial domains of CFQ-R suggest that differentiating between the physical and the psychosocial trajectories in health among adults with CF is critical in evaluating patient-reported outcomes.
Radiation therapy plays a potential curative role in the treatment of patients with non–small-cell lung cancer with locoregional disease who are not surgical candidates and a palliative role for patients with metastatic disease.
According to these findings, lung cancer patients should receive enhanced physical activity intervention during palliative chemotherapy.
IVBs are used more frequently in patients with BMets secondary to BC than PC or LC. Many patients interrupt or discontinue IVB therapy within 12 months of initiation potentially impacting effectiveness.